AltaThera Pharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 6

AltaThera Pharmaceuticals General Information

Description

Developer of specialty pharmaceuticals intended to serve pediatric cardiac patients and adult Atrial Fibrillation patients with effective treatments. The company's product focuses on critical care and alternative therapeutics for unmet medical needs and develops therapies for critical care patients and patients with rare disorders, enabling healthcare providers and hospitals to cure severe disorders improve patients' lives, and help optimize the delivery of quality care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Corporate Office
  • 311 South Wacker Drive
  • Suite 6030
  • Chicago, IL 60606
  • United States
+1 (312) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AltaThera Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AltaThera Pharmaceuticals‘s full profile, request access.

Request a free trial

AltaThera Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of specialty pharmaceuticals intended to serve pediatric cardiac patients and adult Atrial Fibrillation patien
Pharmaceuticals
Chicago, IL
42 As of 2024
00.000
0000000 0000 00.000

000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000 000000000
London, United Kingdom
00 As of 0000
00000
00.00 0000-00-00
000000&0 00000

00 000

mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000 000000000
Irvine, CA
00 As of 0000
00000
00.000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AltaThera Pharmaceuticals Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gyroscope Formerly VC-backed London, United Kingdom 00 00000 000000&0 00000
CG Oncology Formerly VC-backed Irvine, CA 00 00000 00000000 00000
Altravax Formerly VC-backed Sunnyvale, CA 0 00.000 0000000000 00.000
Janssen Global Services Venture Capital-Backed Titusville, NJ 00000 000000 - 000
AB Science Formerly Accelerator/Incubator backed Paris, France 00 00000 000000000 00000
You’re viewing 5 of 17 competitors. Get the full list »

AltaThera Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
John Ellis II Chief Executive Officer
Brandon Kashfian Founder & Chief Business Officer
Stephen O'Sullivan JD Chief Compliance Officer, General Counsel & Director
You’re viewing 3 of 6 executive team members. Get the full list »

AltaThera Pharmaceuticals Board Members (3)

Name Representing Role Since
0000000 0'00000000 AltaThera Pharmaceuticals Chief Compliance Officer, General Counsel & Director 000 0000
You’re viewing 1 of 3 board members. Get the full list »

AltaThera Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AltaThera Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AltaThera Pharmaceuticals‘s full profile, request access.

Request a free trial

AltaThera Pharmaceuticals FAQs

  • When was AltaThera Pharmaceuticals founded?

    AltaThera Pharmaceuticals was founded in 2012.

  • Who is the founder of AltaThera Pharmaceuticals?

    Brandon Kashfian is the founder of AltaThera Pharmaceuticals.

  • Who is the CEO of AltaThera Pharmaceuticals?

    John Ellis II is the CEO of AltaThera Pharmaceuticals.

  • Where is AltaThera Pharmaceuticals headquartered?

    AltaThera Pharmaceuticals is headquartered in Chicago, IL.

  • What is the size of AltaThera Pharmaceuticals?

    AltaThera Pharmaceuticals has 42 total employees.

  • What industry is AltaThera Pharmaceuticals in?

    AltaThera Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is AltaThera Pharmaceuticals a private or public company?

    AltaThera Pharmaceuticals is a Private company.

  • What is AltaThera Pharmaceuticals’s current revenue?

    The current revenue for AltaThera Pharmaceuticals is 000000.

  • How much funding has AltaThera Pharmaceuticals raised over time?

    AltaThera Pharmaceuticals has raised $7.61M.

  • Who are AltaThera Pharmaceuticals’s investors?

    Thornapple River Capital, B. Riley Venture Capital, and Matter Ventures have invested in AltaThera Pharmaceuticals.

  • Who are AltaThera Pharmaceuticals’s competitors?

    Gyroscope, CG Oncology, Altravax, Janssen Global Services, and AB Science are some of the 17 competitors of AltaThera Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »